ストックスクリーナーアプリを入手
0.65
28.57%
-0.26
プレマーケット:
.67
0.02
+3.08%
Clearmind Medicine Inc (CMND) 最新ニュース
Clearmind shares surge as CMND-100 achieves primary endpoint in clinical trial - MSN
Clearmind gets safety board nod to continue alcohol disorder trial - Investing.com
Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial - The Manila Times
Alcohol disorder drug advances after no serious adverse events - Stock Titan
Clearmind Medicine (CMND) raises $1.58M cash via $1.75M notes - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday SessionAdagio Medical Holdings (NASDAQ:ADGM), Allog - Benzinga
Crude Oil Falls Sharply; Wells Fargo Earnings Miss ViewsAvanos Medical (NYSE:AVNS), Clearmind Medicine - Benzinga
Clearmind (Nasdaq: CMND) CMND-100 meets key safety goal in AUD trial - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Clearmind’s CMND-100 meets primary endpoint in phase I/IIa trial - Investing.com India
Clearmind Medicine's CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder - Bitget
Clearmind Medicine Inc. Reports Positive Phase I/IIa Trial Results for CMND-100 in Treating Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine stock surges on phase trial results By Investing.com - Investing.com Australia
Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder - The Manila Times
Clearmind Medicine stock surges on phase trial results - Investing.com
Alcohol use disorder drug clears early safety test at higher dose - Stock Titan
CMND Stock Price, Quote & Chart | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
CMND Forecast, Price Target & Analyst Ratings | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
CMND PE Ratio & Valuation, Is CMND Overvalued - Intellectia AI
CMND Technical Analysis & Stock Price Forecast - Intellectia AI
Clearmind gets safety board approval to continue AUD trial - Investing.com
Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial - TipRanks
Bull Bear: What analysts say about Clearmind Medicine Inc stockWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Clearmind completes treatment for 18 participants in AUD trial By Investing.com - Investing.com South Africa
[EFFECT] Clearmind Medicine Inc. SEC Filing - Stock Titan
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders - MarketScreener
Clearmind completes treatment for 18 participants in AUD trial - Investing.com
Clearmind Medicine Announces Successful Completion Of Treatment Of Cmnd-100 For Alcohol Use Disorder - TradingView — Track All Markets
Clearmind Medicine (Nasdaq: CMND) completes treatment for 18 CMND-100 patients - Stock Titan
Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder - bitget.com
Clearmind says its alcohol disorder drug trial cleared 18 patients - Stock Titan
Oruka Therapeutics and Clearmind Medicine Vie for Investor Dollars - National Today
Clearmind files patent application in India for psychedelic compounds By Investing.com - Investing.com South Africa
Clearmind files patent application in India for psychedelic compounds - in.investing.com
Clearmind Medicine Files Patent Application In India For Next-Gen Psychedelic Compounds To Treat Mental Health Disorders - TradingView
Clearmind Medicine Inc. Files Patent Application in India for Next-Generation Psychedelic Compounds Targeting Mental Health and Addiction - Quiver Quantitative
[6-K] Clearmind Medicine Inc. Current Report (Foreign Issuer) | CMND SEC FilingForm 6-K - Stock Titan
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to ... - Caledonian Record
Market Overview: Is Clearmind Medicine Inc in a bullish channel2026 Big Picture & Real-Time Buy Signal Alerts - baoquankhu1.vn
[POS AM] Clearmind Medicine Inc. SEC Filing - Stock Titan
CMND SEC FilingsClearmind Medici 10-K, 10-Q, 8-K Forms - Stock Titan
CMND Technical Analysis | Trend, Signals & Chart Patterns | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Analyst Upgrade: Is Clearmind Medicine Inc a turnaround story2026 Catalysts & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Form 6K Clearmind Medicine Inc For: 19 March - Investing.com
[6-K] Clearmind Medicine Inc. Cur... | CMND SEC FilingForm 6-K - Stock Titan
Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder - manilatimes.net
Clearmind Medicine Inc. Advances CMND-100 Clinical Trial for Alcohol Use Disorder with Successful Cohort Treatment - Quiver Quantitative
Clearmind Medicine regains compliance with NASDAQ minimum bid price rule - MSN
Clearmind Medicine secures six patents in Hong Kong By Investing.com - Investing.com South Africa
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):